We are live on ! Find out more
FOLD

Amicus Therapeutics
FOLD

Delisted

FOLD was delisted on the 24th of April, 2026.

Back to rankings

95 hedge funds and large institutions have $280M invested in Amicus Therapeutics in 2014 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

292% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 12

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

106% more capital invested

Capital invested by funds: $136M → $280M (+$144M)

69% more call options, than puts

Call options by funds: $4.08M | Put options by funds: $2.41M

58% more funds holding

Funds holding: 60 → 95 (+35)

13% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 16

Holders
95
Holders Change
+35
Holders Change %
+58.33%
% of All Funds
2.76%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.09%
New
47
Increased
18
Reduced
16
Closed
12
Calls
$4.08M
Puts
$2.41M
Net Calls
+$1.67M
Net Calls Change
+$1.62M

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$9.81M
2
RIM
RS Investment Management
California
+$6.54M
3
BIM
Bogle Investment Management
Massachusetts
+$6.45M
4
Millennium Management
Millennium Management
New York
+$6.11M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$4.83M

Top Sellers

Rank Fund Capital Flow
1
PAI
Palo Alto Investors
California
-$10.6M
2
RG
Redmile Group
California
-$10.2M
3
SEP
Sound Energy Partners
Connecticut
-$2.11M
4
UBS AM
UBS AM
Illinois
-$2.03M
5
GTC
Ghost Tree Capital
New York
-$2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$1.46M +$565K +107,907 +78%
Ameriprise
27
Ameriprise
Minnesota
$1.35M +$1.19M +226,803 New
CAM
28
ClariVest Asset Management
California
$1.34M +$1.18M +225,737 New
BA
29
BlackRock Advisors
Delaware
$1.33M +$1.1M +210,320 +1,666%
QBFM
30
QS Batterymarch Financial Management
New York
$1.28M +$1.13M +215,518 New
Two Sigma Advisers
31
Two Sigma Advisers
New York
$1.24M +$1.02M +194,100 +1,296%
SAM
32
Sectoral Asset Management
Quebec, Canada
$1.19M +$1.05M +200,000 New
Point72 Asset Management
33
Point72 Asset Management
Connecticut
$1.17M +$1.03M +195,900 New
Deutsche Bank
34
Deutsche Bank
Germany
$1.1M +$207K +39,443 +27%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$1.08M +$656K +125,235 +220%
Group One Trading
36
Group One Trading
Illinois
$1.01M +$412K +78,546 +87%
SIM
37
Spark Investment Management
New York
$988K +$872K +166,400 New
Connor, Clark & Lunn Investment Management (CC&L)
38
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$813K +$716K +136,600 New
Renaissance Technologies
39
Renaissance Technologies
New York
$776K +$683K +130,400 New
ACM
40
Atika Capital Management
New York
$774K +$681K +130,000 New
BFA
41
BlackRock Fund Advisors
California
$755K +$195K +37,238 +42%
BCM
42
Bridgeway Capital Management
Texas
$702K -$16.8K -3,200 -3%
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$692K – – –
PP
44
PDT Partners
New York
$674K +$594K +113,300 New
DC
45
Deere & Company
Illinois
$596K +$525K +100,172 New
JG
46
Jefferies Group
New York
$595K +$524K +100,000 New
CS
47
Credit Suisse
Switzerland
$576K +$297K +56,667 +141%
ICAP
48
Independence Capital Asset Partners
Colorado
$551K +$485K +92,558 New
Northern Trust
49
Northern Trust
Illinois
$528K -$1.24M -236,266 -73%
Goldman Sachs
50
Goldman Sachs
New York
$523K +$132K +25,182 +40%
1
2
3 4 5

FOLD Hedge Fund Activity: Q3 2014 in Review

95 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q3 2014, worth a combined $280M — up 106% from $136M a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new FOLD positions and 12 closed out — a net gain of 35 holders — while 18 added to existing stakes and 16 trimmed.

The largest buyer was Franklin Resources, opening a new position worth an estimated $9.81M. The largest seller was Palo Alto Investors, cutting an estimated $10.6M.

  • 95 institutional investors held Amicus Therapeutics (FOLD) as of Q3 2014, up from 60 in Q2 2014.
  • Funds reported $280M of Amicus Therapeutics stock for Q3 2014, up 106% quarter-over-quarter.
  • 47 funds opened new Amicus Therapeutics positions in Q3 2014 and 12 closed out, a net change of +35 holders.
  • The largest Amicus Therapeutics buyer in Q3 2014 was Franklin Resources, an estimated $9.81M added.
  • The largest Amicus Therapeutics seller in Q3 2014 was Palo Alto Investors, an estimated $10.6M sold.

Based on aggregated 13F filings for Q3 2014.